NCI-H23 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF1572
Target Cell Organism: Human
Target Cell Alternative Name: H23
Target Cell Name: NCI-H23
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide NCI-H23-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H23
Target Cell Organism
Human
Target Cell Background
NCI-H23 [H23] is an epithelial-like cell that was isolated from the lung of a Black, 51-year-old, male patient with adenocarcinoma. This cell line was deposited by AF Gazdar and JD Minna and can be used in toxicology and cancer research.
Target Cell Alternative Name
H23
Related Diseases
Non Small Cell Lung Cancer
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry